查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1864599

按产品类型、材料类型、技术、应用、最终用户和分销管道分類的医药永续设备市场－2025-2032年全球预测

Sustainable Devices in Pharmaceutical Market by Product Type, Material Type, Technology, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，医药永续设备市场将成长至 670.9 亿美元，复合年增长率为 19.42%。

关键市场统计数据
基准年 2024 162.1亿美元
预计年份：2025年 193.6亿美元
预测年份 2032 670.9亿美元
复合年增长率 (%) 19.42%

建构框架，探讨永续医疗设备应用对製药业产品设计、供应链韧性和监管合规性的紧迫性和策略性影响

随着永续性从企业目标转变为营运要务，医疗器材产业正经历一场意义深远的变革时期。新的监管要求、对产品全生命週期影响的日益关注以及不断演进的医疗系统采购标准，都迫使製造商和供应商重新思考产品设计、材料采购和废弃物管理策略。同时，医疗专业人员和患者也要求医疗器材在维持和提升安全性、易用性和治疗效果的同时，有助于减少对环境的影响。

循环设计、数位化製造和不断发展的采购标准如何共同改变製药业的产品开发、生产地点和供应商策略

加速推动医疗器材的永续性并非渐进式演进，而是一系列变革性的转变，正在重塑研发、生产和商业化流程。价值导向设计原则的适用范围正在扩展，除了临床和成本考量之外，还纳入了生命週期性能指标，鼓励多学科团队从概念到商业化的整个过程中将环境标准纳入产品需求。人工智慧和物联网监控等数位技​​术正被应用于优化材料使用、预测性维护灭菌系统以及降低生产线的消费量。

高关税对医疗器材价值链中製造商和供应商的影响：高关税对采购、供应链韧性和营运选择的影响

美国将于2025年实施的高关税对支持製药设备生产的全球供应商和契约製造製造商产生了迭加效应。关税带来的成本压力使得依赖某些进口零件变得难以为继，迫使企业重新评估其筹资策略，并对灭菌设备零件、品管设备和特种聚合物等关键材料的总到岸成本（TLC）进行建模。因此，采购部门正在加快讨论供应商多元化、合格的国内采购以及双重采购安排，以分散风险并确保临床供应的连续性。

针对永续医疗设备策略的深度細項分析：关联产品原型、材料科学选择、底层技术、应用路径、购买者类型和分销模式

这项細項分析揭示了影响永续医疗设备策略的设计、材料、技术、应用、最终用户和分销管道等诸多因素的组合。所考虑的产品类型包括：给药装置，例如自动注射器、吸入器、预填充式注射器和经皮吸收贴片；物联网和监测系统，包括资料分析平台和感测器解决方案；生产设备，从包衣机到製粒系统和压平机片机；包装设备（泡壳和瓶装填充系统、装盒和袋装解决方案）；品管设备（层析法系统、光谱仪）；以及灭菌设备（高压釜、环氧乙烷灭菌器和伽马射线辐照系统）。对于吸入器而言，干粉吸入器和定量吸入器之间的设计差异会显着影响材料选择和废物处理方法。同时，泡壳包装机和瓶装灌装机的配置也各不相同，从多通道到单通道，从在线连续式到旋转式。

区域法规结构、采购实践和製造生态系统如何影响美洲、欧洲、中东和非洲以及亚太地区永续医疗设备设计的采用

区域趋势正在影响永续医疗器材创新技术的应用、监管预期和投资重点。在美洲，法规结构和采购惯例越来越注重可验证的环境绩效和供应链透明度，促使製造商试点循环包装，并投资建设先进的灭菌和品管设施，以减少耗材的使用。北美临床网路和大型医院系统通常是那些检验在保持临床疗效的同时减少环境影响的医疗器材的早期采用者。

供应商伙伴关係、能力驱动型投资和策略交易正在重新定义医疗设备製造商、合约製造商和优质设备供应商之间的竞争优势。

供应商和原始设备製造商 (OEM) 之间的竞争格局正受到永续性和临床可靠性双重压力的重塑。领先的医疗设备製造商正投资组建设计团队，整合材料科学、法规策略和人体工学，以推动产品开发，从而满足环境和临床要求。随着企业寻求加快新材料的认证週期并降低供应风险，聚合物创新者、自动化专家和灭菌设备供应商之间的策略联盟日益普遍。

为经营团队提供可操作的策略性倡议，以透过设计阶段性措施、供应商多元化、数位化品质系统和试验计画来实施永续性，从而加速其落地实施。

产业领导者应优先采取以下切实可行的步骤，将永续性措施转化为竞争优势：首先，将环境绩效指标纳入产品需求规范和设计流程，在考虑临床和易用性目标的同时，同等重视材料选择、可回收性和生命週期影响。其次，透过与聚合物创新者和增材製造技术专家签订共同开发契约，加速替代材料和製造技术的合格，缩短产品检验生产週期。

调查方法概述：透过访谈、技术咨询、价值链图绘製、生命週期评估原则和情境规划等方法，获得严谨而实用的见解。

本报告整合了一手和二手研究，以确保研究结果的可靠性和可重复性，从而为策略决策提供支援。一手研究包括对医疗设备製造商 (OEM)、契约製造、材料供应商和机构采购部门的高阶主管进行结构化访谈，以及与监管和品质保证专家进行技术咨询。这些定性研究结果与已发布的监管指南、专利、灭菌和包装标准以及关于可生物降解聚合物和增材製造的同行评审文献进行了三角验证。

该评估报告强调了采取综合永续发展措施的策略必要性，以确保临床完整性、营运韧性和长期竞争优势。

永续医疗设备既是挑战也是机会。它们既需要减少对环境的影响，又需要确保安全性、无菌性和治疗效果。能够全面协调设计、采购、生产和监管策略的公司，不仅能够满足相关人员的期望，还能透过减少废弃物、优化能源利用和实现弹性采购来提高营运效率。未来的道路需要严谨的实验、对基础技术的定向投资，以及供应商、监管机构和大型机构采购商之间的合作。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将可生物降解的微针阵列整合到自我给药系统中
  • 推出可重复使用、连网的吸入器，具备智慧剂量监测和分析功能。
  • 利用植物来源聚合物开发可堆肥一次性注射器
  • 推出闭合迴路胰岛素帮浦
  • 扩大口服固体製剂的再生塑胶包装
  • 推出一款采用可再生能源运作的模组化製药生产单元
  • 在活性药物原料药生产中使用先进的排放捕集系统

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依产品类型分類的医药永续设备市场

  • 餵食装置
    • 自动注射器
    • 吸入器
      • 干粉
      • 固定剂量
    • 预填充式注射器
    • 经皮贴剂
  • 物联网和监控系统
    • 数据分析平台
    • 感应器
  • 製造设备
    • 涂布机
    • 造粒系统
    • 压平机
  • 包装设备
    • 泡壳包装机
      • 多车道
      • 单行道
    • 瓶装灌装机
      • 在线连续
      • 旋转式
    • 装盒机
    • 小袋包装机
  • 品管设备
    • 层析法系统
    • 光谱仪
  • 消毒器
    • 高压釜
    • 环氧乙烷灭菌器
    • 伽玛射线辐照系统

9. 依材料类型分類的製药永续设备市场

  • 可生物降解聚合物
    • PBAT
    • PHA
    • PLA
  • 复合材料
  • 玻璃
  • 金属
  • 回收塑胶

10. 按技术分類的製药永续设备市场

  • 3D列印
    • 熔融沈积成型
    • 选择性雷射烧结
    • 立体光刻技术
  • 人工智慧
  • 自动化
  • 物联网赋能
  • 奈米科技

第十一章：按应用分類的製药永续设备市场

  • 低温运输管理
  • 药物递送
    • 吸入
      • 干粉
      • 计量喷雾型
    • 肠外
      • 自动注射器
      • 预填充式注射器
  • 製药生产
  • 药品包装
    • 初级包装
      • 泡壳包装
      • 瓶子
    • 二级包装
      • 纸盒
      • 收缩膜
  • 品管

第十二章：依最终用户分類的医药永续设备市场

  • 契约製造组织
  • 合约研究机构
  • 医院和诊所
  • 製药公司
  • 研究所

13. 按分销管道分類的医药永续设备市场

  • 直销
  • 批发商
  • 电子商务

14. 各地区医药永续设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 依组别分類的医药永续设备市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各国医药永续设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Sartorius AG
    • Corning Incorporated
    • Eppendorf AG
    • GEA Group Aktiengesellschaft
    • Alfa Laval AB
    • IMA SpA
    • Syntegon Technology GmbH
Product Code: MRR-6360D86E7072

The Sustainable Devices in Pharmaceutical Market is projected to grow by USD 67.09 billion at a CAGR of 19.42% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.21 billion
Estimated Year [2025] USD 19.36 billion
Forecast Year [2032] USD 67.09 billion
CAGR (%) 19.42%

Framing the urgency and strategic consequences of sustainable device adoption across product design, supply chain resilience, and regulatory engagement in pharmaceuticals

The pharmaceutical device landscape is undergoing a profound shift as sustainability moves from a corporate aspiration to an operational imperative. New regulatory expectations, rising attention to lifecycle impacts, and evolving procurement criteria from health systems are compelling manufacturers and suppliers to rethink product architecture, materials sourcing, and end-of-life strategies. At the same time, clinicians and patients demand devices that maintain or improve safety, usability, and therapeutic fidelity while contributing to reduced environmental footprints.

Transitioning legacy production lines and entrenched supply relationships requires deliberate strategy and cross-functional coordination. Design teams must reconcile competing constraints: regulatory evidence, sterility requirements, and material performance versus recyclability, biodegradability, and lower carbon intensity. Meanwhile, operations and procurement must secure resilient supply chains for next-generation materials and advanced manufacturing technologies such as additive manufacturing and IoT-enabled quality systems.

This introduction frames the remainder of the executive summary by outlining the structural drivers of change, the practical trade-offs faced by manufacturers, and the types of capabilities that will determine competitive winners. It also highlights the central role that collaborative pilots, targeted investments in automation and analytics, and proactive regulatory engagement play in accelerating adoption of sustainable devices across clinical and commercial pathways.

How circular design, digital manufacturing, and evolving procurement standards are jointly transforming product development, production footprints, and supplier strategies in pharmaceuticals

Accelerating sustainability in pharmaceutical devices is not an incremental evolution; it represents a set of transformative shifts that are reshaping R&D, manufacturing, and commercialization. Design-to-value principles are expanding to include lifecycle performance metrics alongside clinical and cost considerations, prompting interdisciplinary teams to embed environmental criteria into product requirements from concept through commercialization. Digital technologies such as artificial intelligence and IoT-enabled monitoring are being deployed to optimize material usage, predict maintenance of sterilization systems, and reduce energy intensity across production lines.

Manufacturing footprints are re-evaluated as firms consider nearshoring and modular production to reduce scope 3 emissions and improve supply continuity. At the same time, materials science advances-particularly in biodegradable polymers, composite materials, and recycled plastics-are enabling alternative packaging and component strategies while demanding new validation approaches. Quality control ecosystems are evolving to incorporate analytics-driven inspection and non-destructive testing that preserve product integrity while reducing waste of in-process goods.

These shifts are reinforced by changing procurement behaviors among large institutional buyers who increasingly solicit environmental performance data, and by investors who reward measurable sustainability plans. As a result, companies that integrate circular design, digital manufacturing, and robust lifecycle analytics will unlock operational efficiencies and meet the heightened expectations of regulators, payers, and end users.

Implications of elevated tariffs on procurement, supply resiliency, and operational choices for manufacturers and suppliers in the pharmaceutical device value chain

The introduction of elevated tariff measures in the United States during 2025 has created compounding effects for global suppliers and contract manufacturers supporting pharmaceutical device production. Tariff-driven cost pressure has made reliance on certain imported components less tenable, prompting companies to revisit sourcing strategies and to model the total landed cost of critical inputs including sterilization equipment parts, quality control instruments, and specialized polymers. Consequently, procurement teams have accelerated conversations about supplier diversification, qualified domestic sourcing, and dual-sourcing arrangements to mitigate exposure and ensure continuity of clinical supply.

In response, some manufacturers have initiated near-term operational adjustments such as reconfiguring logistics to utilize alternative ports or transport modalities, renegotiating long-term supply contracts to include tariff pass-through clauses, and advancing local content in new product specifications. These tactical responses are often combined with strategic investments in automation and vertical integration to offset higher input costs and to protect gross margins while preserving compliance and performance standards.

Moreover, the tariff environment has amplified the need for robust regulatory and customs expertise as product classifications and tariff codes intersect with medical device regulations. Companies that proactively engage cross-functional teams-legal, trade compliance, procurement, and regulatory affairs-can better forecast operational impacts, structure resilient supplier networks, and sequence capital projects to maintain competitiveness amid evolving trade policies.

Deep segmentation insight connecting product archetypes, material science choices, enabling technologies, application pathways, buyer types, and distribution models for sustainable device strategies

Segmentation analysis reveals the breadth of design, material, technological, application, end user, and distribution permutations shaping sustainable device strategies. Product Type considerations span Delivery Devices such as auto-injectors, inhalers, prefilled syringes, and transdermal patches; IoT and monitoring systems that include data analytics platforms and sensor solutions; Manufacturing Equipment ranging from coating machines to granulation systems and tablet presses; Packaging Equipment including blister and bottle filling systems, cartoning, and sachet packaging solutions; Quality Control Equipment such as chromatography systems and spectrometers; and Sterilization Equipment including autoclaves, ethylene oxide sterilizers, and gamma irradiation systems. Within inhalers, distinctions between dry powder and metered dose designs materially influence materials and end-of-life pathways, while blister and bottle filling machines vary in configuration from multi-lane to single-lane and inline to rotary formats.

Material Type choices intersect with design intent and regulatory constraints and include biodegradable polymers-PBAT, PHA, and PLA-alongside composite materials, glass, metal, and recycled plastics. Technology segmentation highlights additive manufacturing modalities like fused deposition modeling, selective laser sintering, and stereolithography; advanced automation and artificial intelligence for process control; IoT-enabled platforms for telemetry and predictive maintenance; and nascent applications of nanotechnology for material performance.

Application segmentation covers cold chain management, drug delivery across inhalation and parenteral routes, drug manufacturing, packaging with distinctions between primary and secondary formats, and quality control. End user segmentation ranges from contract manufacturing and research organizations to hospitals, pharmaceutical companies, and research institutes, while distribution channels span direct sales, distributors, and e-commerce. Understanding how these segments interrelate enables companies to prioritize product portfolios, align material choices with regulatory paths, and tailor commercial models to distinct buyer needs.

How regional regulatory frameworks, procurement behaviors, and manufacturing ecosystems are influencing the adoption of sustainable device designs across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics shape innovation adoption, regulatory expectations, and investment priorities for sustainable pharmaceutical devices. In the Americas, regulatory frameworks and procurement practices are increasingly oriented toward demonstrable environmental performance and supply chain transparency, driving manufacturers to pilot circular packaging and invest in advanced sterilization and quality control equipment that reduce consumable usage. North American clinical networks and large hospital systems often serve as early adopters for devices validated to maintain clinical outcomes while lowering environmental impact.

Across Europe, Middle East & Africa, regulatory harmonization and extended producer responsibility initiatives are influencing design choices, particularly for packaging and end-of-life pathways. European purchasers frequently require lifecycle documentation and end-of-life takeback plans, which encourages manufacturers to incorporate recyclable or biodegradable materials and to partner with reverse-logistics providers. In parallel, markets within the Middle East & Africa demonstrate uneven infrastructure maturity, creating opportunities for modular manufacturing and localized service models that can address cold chain and sterilization challenges at lower scale.

In Asia-Pacific, fast-growing manufacturing capacity, rapid adoption of digital manufacturing technologies, and a dense supplier ecosystem for polymers and electronics enable rapid prototyping and cost-efficient scaling. However, varying regulatory regimes and differing waste management infrastructures across countries require tailored strategies for material selection, sterilization modalities, and distribution models. Sensitivity to regional procurement timelines and local content expectations is essential when deploying new sustainable devices across these diverse geographies.

How supplier partnerships, capability-focused investments, and strategic transactions are redefining competitive advantage among device makers, CMOs, and quality equipment providers

Competitive dynamics among suppliers and OEMs are being reshaped by the simultaneous pressures of sustainability performance and clinical reliability. Leading device manufacturers are investing in integrated design teams that combine materials science, regulatory strategy, and human factors to advance products that satisfy both environmental and clinical requirements. Strategic partnerships between polymer innovators, automation specialists, and sterilization equipment providers are common, as firms seek to accelerate qualification cycles and de-risk supply for novel materials.

At the same time, contract manufacturing organizations and research institutions play a pivotal role in piloting alternative manufacturing processes such as additive manufacturing and in implementing IoT-enabled quality platforms that allow for data-driven validation. Established quality equipment vendors are extending their portfolios to include analytics and non-destructive testing capabilities that minimize scrap and support continuous release models.

Mergers, acquisitions, and minority investments remain tools for acquiring capabilities rapidly, particularly in areas such as biodegradable polymer production, sensor miniaturization, and AI-driven quality control. Companies that succeed will combine product innovation with resilient supply networks, transparent lifecycle data, and commercial models that align incentives across OEMs, suppliers, and large institutional buyers.

Actionable strategic moves for executives to operationalize sustainability through design gating, supplier diversification, digital quality systems, and pilot programs that accelerate adoption

Industry leaders should prioritize a set of actionable initiatives to convert sustainability commitments into competitive advantage. First, embed environmental performance metrics into product requirement documents and design gates so that material selection, recyclability, and lifecycle impacts are considered alongside clinical and usability objectives. Second, accelerate qualification of alternative materials and manufacturing technologies through joint development agreements with polymer innovators and additive manufacturing specialists, thereby shortening time to validated production.

Third, strengthen procurement resilience by diversifying suppliers, qualifying domestic or nearshore sources for critical components, and including trade-compliance provisions in contracts to manage tariff volatility. Fourth, deploy digital quality platforms and sensor-enabled monitoring to reduce waste, enable predictive maintenance of sterilization and packaging equipment, and support data-driven regulatory submissions. Fifth, engage proactively with regulatory bodies and large institutional buyers to co-develop acceptance criteria for new materials and circular packaging models, thus reducing adoption friction.

Finally, design pilot programs that pair clinical performance validation with environmental outcome measurement and commercial pathway testing. These pilots should be structured to generate robust evidence for regulators and purchasers while providing a repeatable template for scaling successful device designs across regions and distribution channels.

Methodological overview detailing interviews, technical consultations, value chain mapping, lifecycle assessment principles, and scenario planning used to produce rigorous, actionable findings

This report synthesizes primary and secondary research to ensure robust, reproducible findings that support strategic decision-making. Primary inputs include structured interviews with senior executives across device OEMs, contract manufacturers, materials providers, and institutional buyers, combined with technical consultations with regulatory and quality assurance experts. These qualitative insights were triangulated with public regulatory guidances, patents, standards for sterilization and packaging, and peer-reviewed literature on biodegradable polymers and additive manufacturing.

Analytical methods include value chain mapping to identify emissions and waste hotspots, capability gap analysis to assess readiness for new materials and technologies, and scenario-based planning to evaluate responses to trade policy shifts and supply disruptions. Where appropriate, lifecycle thinking informed material and packaging recommendations, and cross-functional workshops validated the operational feasibility of proposed interventions. The methodology emphasizes transparency in sources and assumptions and includes appendices with interview protocols, regulatory references, and technology validation criteria to facilitate independent review and replication.

Concluding synthesis emphasizing the strategic necessity of integrated sustainability initiatives to secure clinical integrity, operational resilience, and long-term competitive advantage

Sustainable devices represent both a challenge and an opportunity: the imperative to reduce environmental impact intersects with the need to preserve safety, sterility, and therapeutic efficacy. Companies that approach this transition holistically-aligning design, procurement, manufacturing, and regulatory strategy-will not only meet stakeholder expectations but also capture operational efficiencies through waste reduction, energy optimization, and resilient sourcing. The path forward requires disciplined experimentation, targeted investments in enabling technologies, and collaboration across suppliers, regulators, and large institutional buyers.

Decision-makers should view sustainability initiatives as strategic projects with defined milestones, cross-functional sponsors, and measurable outcomes rather than as peripheral corporate social responsibility activities. By prioritizing pilots that generate both clinical and environmental evidence, and by building modular production capabilities that can scale regionally, organizations can de-risk innovation and accelerate adoption. Ultimately, the companies that integrate circularity into their core product development and commercialization processes will be best positioned to serve evolving healthcare systems while strengthening long-term competitiveness.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of biodegradable microneedle arrays for self-administered drug delivery
  • 5.2. Adoption of reusable connected inhalers with smart dose monitoring and analytics
  • 5.3. Development of compostable single-use syringes using plant-based polymers
  • 5.4. Implementation of closed-loop insulin pumps with energy-efficient wireless charging
  • 5.5. Expansion of recycled plastic packaging for oral solid dosage formulations
  • 5.6. Deployment of modular pharmaceutical manufacturing units powered by renewable energy
  • 5.7. Use of advanced emission capture systems in active pharmaceutical ingredient production

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sustainable Devices in Pharmaceutical Market, by Product Type

  • 8.1. Delivery Devices
    • 8.1.1. Auto-Injectors
    • 8.1.2. Inhalers
      • 8.1.2.1. Dry Powder
      • 8.1.2.2. Metered Dose
    • 8.1.3. Prefilled Syringes
    • 8.1.4. Transdermal Patches
  • 8.2. IoT & Monitoring Systems
    • 8.2.1. Data Analytics Platforms
    • 8.2.2. Sensors
  • 8.3. Manufacturing Equipment
    • 8.3.1. Coating Machines
    • 8.3.2. Granulation Systems
    • 8.3.3. Tablet Presses
  • 8.4. Packaging Equipment
    • 8.4.1. Blister Packaging Machines
      • 8.4.1.1. Multi-Lane
      • 8.4.1.2. Single-Lane
    • 8.4.2. Bottle Filling Machines
      • 8.4.2.1. Inline
      • 8.4.2.2. Rotary
    • 8.4.3. Cartoning Machines
    • 8.4.4. Sachet Packaging Machines
  • 8.5. Quality Control Equipment
    • 8.5.1. Chromatography Systems
    • 8.5.2. Spectrometers
  • 8.6. Sterilization Equipment
    • 8.6.1. Autoclaves
    • 8.6.2. Ethylene Oxide Sterilizers
    • 8.6.3. Gamma Irradiation Systems

9. Sustainable Devices in Pharmaceutical Market, by Material Type

  • 9.1. Biodegradable Polymers
    • 9.1.1. PBAT
    • 9.1.2. PHA
    • 9.1.3. PLA
  • 9.2. Composite Materials
  • 9.3. Glass
  • 9.4. Metal
  • 9.5. Recycled Plastics

10. Sustainable Devices in Pharmaceutical Market, by Technology

  • 10.1. 3D Printing
    • 10.1.1. Fused Deposition Modeling
    • 10.1.2. Selective Laser Sintering
    • 10.1.3. Stereolithography
  • 10.2. Artificial Intelligence
  • 10.3. Automation
  • 10.4. IoT-Enabled
  • 10.5. Nanotechnology

11. Sustainable Devices in Pharmaceutical Market, by Application

  • 11.1. Cold Chain Management
  • 11.2. Drug Delivery
    • 11.2.1. Inhalation
      • 11.2.1.1. Dry Powder
      • 11.2.1.2. Metered Dose
    • 11.2.2. Parenteral
      • 11.2.2.1. Auto-Injectors
      • 11.2.2.2. Prefilled Syringes
  • 11.3. Drug Manufacturing
  • 11.4. Drug Packaging
    • 11.4.1. Primary Packaging
      • 11.4.1.1. Blister Packaging
      • 11.4.1.2. Bottles
    • 11.4.2. Secondary Packaging
      • 11.4.2.1. Cartons
      • 11.4.2.2. Shrink Wrap
  • 11.5. Quality Control

12. Sustainable Devices in Pharmaceutical Market, by End User

  • 12.1. Contract Manufacturing Organizations
  • 12.2. Contract Research Organizations
  • 12.3. Hospitals & Clinics
  • 12.4. Pharmaceutical Companies
  • 12.5. Research Institutes

13. Sustainable Devices in Pharmaceutical Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. E-Commerce

14. Sustainable Devices in Pharmaceutical Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Sustainable Devices in Pharmaceutical Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Sustainable Devices in Pharmaceutical Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Thermo Fisher Scientific Inc.
    • 17.3.2. Danaher Corporation
    • 17.3.3. Merck KGaA
    • 17.3.4. Sartorius AG
    • 17.3.5. Corning Incorporated
    • 17.3.6. Eppendorf AG
    • 17.3.7. GEA Group Aktiengesellschaft
    • 17.3.8. Alfa Laval AB
    • 17.3.9. IMA S.p.A.
    • 17.3.10. Syntegon Technology GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DELIVERY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTO-INJECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTO-INJECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTO-INJECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTO-INJECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INHALERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DRY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METERED DOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METERED DOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METERED DOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METERED DOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METERED DOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METERED DOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PREFILLED SYRINGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PREFILLED SYRINGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PREFILLED SYRINGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PREFILLED SYRINGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TRANSDERMAL PATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TRANSDERMAL PATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TRANSDERMAL PATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TRANSDERMAL PATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY IOT & MONITORING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DATA ANALYTICS PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DATA ANALYTICS PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DATA ANALYTICS PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DATA ANALYTICS PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DATA ANALYTICS PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY DATA ANALYTICS PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COATING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COATING MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COATING MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COATING MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COATING MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COATING MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GRANULATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GRANULATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GRANULATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GRANULATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GRANULATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GRANULATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TABLET PRESSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TABLET PRESSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TABLET PRESSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TABLET PRESSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TABLET PRESSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TABLET PRESSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PACKAGING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKAGING MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MULTI-LANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MULTI-LANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MULTI-LANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MULTI-LANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MULTI-LANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MULTI-LANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SINGLE-LANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SINGLE-LANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SINGLE-LANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SINGLE-LANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SINGLE-LANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SINGLE-LANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BOTTLE FILLING MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY INLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ROTARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ROTARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ROTARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ROTARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ROTARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ROTARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CARTONING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CARTONING MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CARTONING MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CARTONING MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CARTONING MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CARTONING MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SACHET PACKAGING MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SACHET PACKAGING MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SACHET PACKAGING MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SACHET PACKAGING MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SACHET PACKAGING MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SACHET PACKAGING MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY QUALITY CONTROL EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SPECTROMETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SPECTROMETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SPECTROMETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SPECTROMETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SPECTROMETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY SPECTROMETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTOCLAVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTOCLAVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTOCLAVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTOCLAVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTOCLAVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY AUTOCLAVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ETHYLENE OXIDE STERILIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ETHYLENE OXIDE STERILIZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ETHYLENE OXIDE STERILIZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ETHYLENE OXIDE STERILIZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ETHYLENE OXIDE STERILIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY ETHYLENE OXIDE STERILIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GAMMA IRRADIATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GAMMA IRRADIATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GAMMA IRRADIATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GAMMA IRRADIATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GAMMA IRRADIATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GAMMA IRRADIATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PBAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PBAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PBAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PBAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PBAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PBAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PHA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PHA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PHA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PHA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PHA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PHA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PLA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PLA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PLA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PLA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PLA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY PLA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COMPOSITE MATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COMPOSITE MATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COMPOSITE MATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY COMPOSITE MATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY METAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLED PLASTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLED PLASTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLED PLASTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLED PLASTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLED PLASTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY RECYCLED PLASTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY 3D PRINTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL SUSTAINABLE DEVICES IN PHARMACEUTICAL MARKET SIZE, BY FUSED DEPOSITION MODELING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL SUSTAINABLE DEVICES IN PHARMACEU